151 related articles for article (PubMed ID: 11202216)
1. Treatment of type 2 diabetes mellitus in children and adolescents.
Silverstein JH; Rosenbloom AL
J Pediatr Endocrinol Metab; 2000; 13 Suppl 6():1403-9. PubMed ID: 11202216
[TBL] [Abstract][Full Text] [Related]
2. Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.
Plosker GL; Figgitt DP
Pharmacoeconomics; 2004; 22(6):389-411. PubMed ID: 15099124
[TBL] [Abstract][Full Text] [Related]
3. Focus on insulin resistance in type 2 diabetes: therapeutic implications.
Reusch JE
Diabetes Educ; 1998; 24(2):188-93. PubMed ID: 9555358
[TBL] [Abstract][Full Text] [Related]
4. Oral antidiabetic agents: current role in type 2 diabetes mellitus.
Krentz AJ; Bailey CJ
Drugs; 2005; 65(3):385-411. PubMed ID: 15669880
[TBL] [Abstract][Full Text] [Related]
5. Changes of the glycemic control and therapeutic regimen for diabetes mellitus in the Japanese patients on hemodialysis.
Sanai T; Tada H; Ono T; Fukumitsu T
Diabetes Metab Syndr; 2015; 9(4):244-6. PubMed ID: 25866098
[TBL] [Abstract][Full Text] [Related]
6. Type II diabetes mellitus.
Edelman SV
Adv Intern Med; 1998; 43():449-500. PubMed ID: 9506190
[TBL] [Abstract][Full Text] [Related]
7. Management of hyperglycemia in minority children with type 2 diabetes mellitus.
Castells S
J Pediatr Endocrinol Metab; 2002 Apr; 15 Suppl 1():531-40. PubMed ID: 12017228
[TBL] [Abstract][Full Text] [Related]
8. Challenges Related to Glycemic Control in Type 2 Diabetes Mellitus Patients.
Kheirandish M; Mahboobi H; Yazdanparast M; Kamal MA
Curr Drug Metab; 2017; 18(2):157-162. PubMed ID: 28093996
[TBL] [Abstract][Full Text] [Related]
9. Responses to acute exercise in type 2 diabetes, with an emphasis on metabolism and interaction with oral hypoglycemic agents and food intake.
Galbo H; Tobin L; van Loon LJ
Appl Physiol Nutr Metab; 2007 Jun; 32(3):567-75. PubMed ID: 17510698
[TBL] [Abstract][Full Text] [Related]
10. Management of blood glucose in type 2 diabetes mellitus.
Ripsin CM; Kang H; Urban RJ
Am Fam Physician; 2009 Jan; 79(1):29-36. PubMed ID: 19145963
[TBL] [Abstract][Full Text] [Related]
11. Treating dual defects in diabetes: insulin resistance and insulin secretion.
Bohannon NJ
Am J Health Syst Pharm; 2002 Dec; 59 Suppl 9():S9-13. PubMed ID: 12489381
[TBL] [Abstract][Full Text] [Related]
12. Secondary failure to oral hypoglycaemic agents in non-obese patients with non-insulin-dependent diabetes is related to reduced insulin release.
Pontiroli AE; Calderara A; Maffi P; Bonisolli L; Carenini A; Piatti PM; Monti LD; Gallus G; Pozza G; Illeni MT
Diabete Metab; 1989; 15(2):79-84. PubMed ID: 2661281
[TBL] [Abstract][Full Text] [Related]
13. [A 50-year history of new drugs in Japan-the development and progress of anti-diabetic drugs and the epidemiological aspects of diabetes mellitus].
Ozawa H; Murai Y; Ozawa T
Yakushigaku Zasshi; 2003; 38(1):11-27. PubMed ID: 14570054
[TBL] [Abstract][Full Text] [Related]
14. Oral hypoglycemic agents: insulin secretagogues, alpha-glucosidase inhibitors and insulin sensitizers.
Raptis SA; Dimitriadis GD
Exp Clin Endocrinol Diabetes; 2001; 109 Suppl 2():S265-87. PubMed ID: 11460577
[TBL] [Abstract][Full Text] [Related]
15. Eight weeks of treatment with long-acting GLP-1 analog taspoglutide improves postprandial insulin secretion and sensitivity in metformin-treated patients with type 2 diabetes.
Gastaldelli A; Nauck MA; Balena R
Metabolism; 2013 Sep; 62(9):1330-9. PubMed ID: 23831441
[TBL] [Abstract][Full Text] [Related]
16. The effects of metformin on body mass index and glucose tolerance in obese adolescents with fasting hyperinsulinemia and a family history of type 2 diabetes.
Freemark M; Bursey D
Pediatrics; 2001 Apr; 107(4):E55. PubMed ID: 11335776
[TBL] [Abstract][Full Text] [Related]
17. Therapy for type 2 diabetes mellitus.
Elson DF; Meredith M
WMJ; 1998 Mar; 97(3):49-54. PubMed ID: 9540451
[TBL] [Abstract][Full Text] [Related]
18. [Etiology of and therapy for type-2 diabetes mellitus].
Kazuga M
Nihon Naika Gakkai Zasshi; 2004 Mar; 93(3):527-31. PubMed ID: 15052815
[No Abstract] [Full Text] [Related]
19. [Therapies for newly-onset diabetic patients].
Kawamori R
Nihon Rinsho; 2005 Feb; 63 Suppl 2():525-32. PubMed ID: 15779435
[No Abstract] [Full Text] [Related]
20. Drug interactions of clinical importance with antihyperglycaemic agents: an update.
Scheen AJ
Drug Saf; 2005; 28(7):601-31. PubMed ID: 15963007
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
